These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37596374)

  • 41. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score.
    Peters M; Eldred-Evans D; Kurver P; Falagario UG; Connor MJ; Shah TT; Verhoeff JJC; Taimen P; Aronen HJ; Knaapila J; Montoya Perez I; Ettala O; Stabile A; Gandaglia G; Fossati N; Martini A; Cucchiara V; Briganti A; Lantz A; Picker W; Haug ES; Nordström T; Tanaka MB; Reddy D; Bass E; van Rossum PSN; Wong K; Tam H; Winkler M; Gordon S; Qazi H; Boström PJ; Jambor I; Ahmed HU
    Eur Urol; 2022 Nov; 82(5):559-568. PubMed ID: 35963650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
    Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
    Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
    Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
    Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of clinically significant prostate cancer by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in smaller prostates.
    Dahl DM; Kim MM; Wu S; Lin SX; Crotty RK; Cornejo KM; Harisinghani MG; Feldman AS; Wu CL
    Urol Oncol; 2022 Oct; 40(10):451.e9-451.e14. PubMed ID: 36008257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI.
    Nguyen TA; Fourcade A; Zambon A; Saout K; Deruelle C; Joulin V; Tissot V; Doucet L; Rozet F; Fournier G; Valeri A
    Urol Oncol; 2023 Aug; 41(8):354.e11-354.e18. PubMed ID: 37391283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy.
    Chuang HW; Wu S; Lin SX; Zhao T; Kim MM; Harisinghani M; Feldman AS; Dahl DM; Wu CL
    Diagn Pathol; 2023 Sep; 18(1):101. PubMed ID: 37697349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
    Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches.
    Loy LM; Lim GH; Leow JJ; Lee CH; Tan TW; Tan CH
    Urol Oncol; 2020 Aug; 38(8):650-660. PubMed ID: 32505458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How many cores are enough? Optimizing the transperineal prostate biopsy template.
    Schaufler C; Daigle R; Singhaviranon S; Gjertson CK; Albertsen PC; Ristau BT
    Urol Oncol; 2022 May; 40(5):191.e1-191.e7. PubMed ID: 35067430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter Analysis.
    Hung M; Ross AE; Li EV; Pavlovich CP; Fletcher SA; Gereta S; Zhang TR; McClure TD; Allaf ME; Schaeffer EM; Hu JC
    Urology; 2024 Apr; 186():91-97. PubMed ID: 38387509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement?
    Wroclawski ML; Kayano PP; Amaral BS; Mariotti GC; Yamauchi FI; Cha JD; Carneiro A; Korkes F; Vitalli AS; Mussi TC; Lemos GC; Baroni RH
    Abdom Radiol (NY); 2020 Oct; 45(10):3278-3282. PubMed ID: 31974659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic efficacy and safety of transperineal prostate targeted and systematic biopsy: The preliminary experience of first 100 cases.
    Mehmood S; Alothman KI; Alwehaibi A; Alhashim SM
    Arch Ital Urol Androl; 2021 Jun; 93(2):127-131. PubMed ID: 34286542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical study of multifactorial diagnosis in prostate biopsy.
    Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
    Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate.
    Hsieh PF; Chang TY; Lin WC; Chang H; Chang CH; Huang CP; Yang CR; Chen WC; Chang YH; Wang YD; Huang WC; Wu HC
    BMC Urol; 2022 Apr; 22(1):72. PubMed ID: 35488246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
    Schlenker B; Apfelbeck M; Armbruster M; Chaloupka M; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 71(2):165-170. PubMed ID: 30562897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
    Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
    Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate cancer detection using magnetic resonance imaging-transrectal ultrasound fusion biopsy: A retrospective cohort study.
    Pratihar SK; Khanna A; Vasudeo V; Gupta R; Saurabh N; Kumar B; Ali M; Akotkar SS; Rawal SK; Singh A
    Indian J Urol; 2023; 39(4):297-302. PubMed ID: 38077193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.